Viewing StudyNCT00436241



Ignite Creation Date: 2024-05-05 @ 5:21 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00436241
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2007-02-16

Brief Title: A Study of Xeloda Capecitabine as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Organization Data

Organization: Hoffmann-La Roche
Class: INDUSTRY
Study ID: ML20734
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Hoffmann-La Roche
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators